DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Attanasio R, Baldelli R, Pivonello R. et al.
Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly.
J Clin Endocrinol Metab 2003; 88: 5258-5265
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.